| HOME >> MEDICINE >> TECHNOLOGY |
5.2.2 Labconco Corporation
5.2.2.1 Overview
5.2.2.2 Global Presence
5.2.2.3 Product Focus
5.2.2.4 Dry Ice Benchtop Freeze Dry System
5.2.2.5 FreeZone Benchtop Freeze Dry Systems
5.2.2.6 FreeZone Console Freeze Dry Systems
5.2.2.7 FreeZone Plus Cascade Freeze Dry Systems
5.2.2.8 FreeZone Triad Freeze Dry Systems
5.2.2.9 Labconco Freeze Dry Accessories
5.2.2.10 R&D
5.2.2.11 Future Outlook
5.2.3 Vetter Pharma-Fertigung
5.2.3.1 An Overview
5.2.3.2 Global Presence
5.2.3.3 Business Interests
5.2.3.3.1 Vetter Development Service
5.2.3.3.2 Vetter Commercial Manufacturing
5.2.3.3.3 Vetter Solutions
5.2.3.4 Capabilities
5.2.3.5 R&D
5.2.3.6 Product Focus
5.2.3.6.1 Dual-Chamber Technology
5.2.3.7 Future Outlook
5.2.4 Piramal Pharma Solutions
5.2.4.1 Overview
5.2.4.2 Global Presence
5.2.4.3 Strengths and Capabilities
6. SWOT Analysis of the Lyophilisation Technology Market
6.1 Introduction
6.2 Commercial Drivers of the Lyophilisation Technology Market
6.3 Commercial Restraints for the Lyophilisation Technology Market
6.3.1 High Entry Barriers to Sector
6.3.2 Product Formulation Challenges
6.3.3 R&D Stage for Lyophilised Products
6.3.4 Scale-up Stage for Lyophilised Products
6.3.5 Main Issues at Large Scale Production Stage for Lyophilised Products
6.3.6 Main Challenges in a Freeze Drying Plant
6.3.7 Main Issues in Production
6.3.8 Typical Deficiencies in a Freeze Drying Process
6.4 Challenges Facing the Lyophilisation Technology Industry and Market
6.4.1 Spray Drying of Biopharmaceuticals
6.4.2 Other Methods in Development
6.4.2.1 Roche's Precipitation Meth
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |